» Articles » PMID: 22633126

Pulmonary Artery Pressure in Cystic Fibrosis Adults: Characteristics, Clinical Correlates and Long-term Follow-up

Overview
Journal J Cyst Fibros
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2012 May 29
PMID 22633126
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We examined pulmonary artery pressure (PAP) characteristics of CF adults, studied clinical correlates and long-term survival.

Methods: Comprehensive clinical data were collected and Doppler echocardiography was used to estimate PAP in 109 stable CF adults and 50 healthy controls.

Results: CF patients had lower day and night-time oxygen status, elevated CRP and BNP, and elevated PAP (27.7(13.2, 62.8) mmHg patients v 17.9(11.3, 30.9) mmHg controls, p<0.001). Even patients with mild pulmonary disease had raised PAP. PAP measurements strongly correlated with arterial partial pressure of oxygen (PaO(2), r=-0.673, p<0.001), and FEV(1) percentage predicted (FEV(1)%, r=-0.642, p<0.001) which were both independent predictors of PAP. At 10 year follow up PAP measurements were related to survival but FEV(1)% and PaO(2) were both stronger predictors of death.

Conclusions: PAP is raised in CF adults and correlates with pulmonary disease severity. Unlike PaO(2) and FEV(1)%, it does not appear to be an independent prognostic marker.

Citing Articles

Patent Foramen Ovale and Oxygenation in Patients with Cystic Fibrosis.

Belt H, Enakpene E, Jensen J, Moe A, Carveth H, Cahill B Respiration. 2024; 104(3):188-199.

PMID: 39378862 PMC: 11885056. DOI: 10.1159/000541892.


Interpreting risk reduction in clinical trials for pulmonary arterial hypertension.

Lajoie A, Bonnet S, Lacasse Y, Lega J, Provencher S Eur Respir Rev. 2018; 27(148).

PMID: 29769296 PMC: 9488718. DOI: 10.1183/16000617.0020-2018.


Pregnancy and cystic fibrosis: Approach to contemporary management.

Geake J, Tay G, Callaway L, Bell S Obstet Med. 2016; 7(4):147-55.

PMID: 27512443 PMC: 4934991. DOI: 10.1177/1753495X14554022.


Polysomnographic differences associated with pulmonary hypertension in patients with advanced lung disease due to cystic fibrosis.

Hayes Jr D, Daniels C, Kirkby S, Kopp B, Nicholson K, Nance A Lung. 2014; 192(3):413-9.

PMID: 24671311 DOI: 10.1007/s00408-014-9573-x.


Pulmonary hypertension survival effects and treatment options in cystic fibrosis.

Tonelli A Curr Opin Pulm Med. 2013; 19(6):652-61.

PMID: 24048083 PMC: 4009690. DOI: 10.1097/MCP.0b013e3283659e9f.